| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|
Dirix, Luc Y.
|
|
2017
|
167 |
3 |
p. 671-686
|
artikel
|
| 2 |
BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation
|
Brianese, Rafael Canfield
|
|
2017
|
167 |
3 |
p. 803-814
|
artikel
|
| 3 |
Breast cancer-related paraneoplastic neurologic disease
|
Murphy, Brittany L.
|
|
2017
|
167 |
3 |
p. 771-778
|
artikel
|
| 4 |
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
|
Nguyen, Frédérique
|
|
2017
|
167 |
3 |
p. 635-648
|
artikel
|
| 5 |
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes
|
Kerekes, Daniel
|
|
2017
|
167 |
3 |
p. 649-658
|
artikel
|
| 6 |
Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery
|
Punglia, Rinaa S.
|
|
2017
|
167 |
3 |
p. 751-759
|
artikel
|
| 7 |
Does the elevation of CAMLs predict metastatic breast cancer patients’ survival?
|
Tan, Qixing
|
|
2017
|
167 |
3 |
p. 819
|
artikel
|
| 8 |
Dose adjustment in obese breast cancer patients receiving neoadjuvant chemotherapy might have an impact on survival
|
Altundag, Kadri
|
|
2017
|
167 |
3 |
p. 821
|
artikel
|
| 9 |
Duration of trastuzumab in HER2-positive metastatic breast cancer after complete remission: still debatable issue?
|
Altundag, Kadri
|
|
2017
|
167 |
3 |
p. 815
|
artikel
|
| 10 |
Efficacy and safety in older patient subsets in studies of endocrine monotherapy versus combination therapy in patients with HR+/HER2− advanced breast cancer: a review
|
Freedman, Rachel A.
|
|
2017
|
167 |
3 |
p. 607-614
|
artikel
|
| 11 |
Hormone receptor-positive invasive lobular and ductal carcinoma of the breast have comparable hormone receptor expression levels both if detected by screening and clinically
|
Ravaioli, Alessandra
|
|
2017
|
167 |
3 |
p. 817-818
|
artikel
|
| 12 |
Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ
|
Sopik, Victoria
|
|
2017
|
167 |
3 |
p. 787-795
|
artikel
|
| 13 |
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer
|
Rimawi, Mothaffar F.
|
|
2017
|
167 |
3 |
p. 731-740
|
artikel
|
| 14 |
Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review
|
Lambert, Leah K.
|
|
2017
|
167 |
3 |
p. 615-633
|
artikel
|
| 15 |
Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain
|
Lustberg, Maryam B.
|
|
2017
|
167 |
3 |
p. 709-718
|
artikel
|
| 16 |
Reclassifying HER2-equivocal disease
|
Sorscher, Steven
|
|
2017
|
167 |
3 |
p. 823
|
artikel
|
| 17 |
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial
|
Sonke, Gabe S.
|
|
2017
|
167 |
3 |
p. 659-669
|
artikel
|
| 18 |
Safety of fertility preservation in breast cancer patients in a register-based matched cohort study
|
Rodriguez-Wallberg, Kenny A.
|
|
2017
|
167 |
3 |
p. 761-769
|
artikel
|
| 19 |
Sensation of the autologous reconstructed breast improves quality of life: a pilot study
|
Cornelissen, Anouk J. M.
|
|
2017
|
167 |
3 |
p. 687-695
|
artikel
|
| 20 |
The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT
|
Kirkham, Amy A.
|
|
2017
|
167 |
3 |
p. 719-729
|
artikel
|
| 21 |
The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women’s Health Initiative observational study
|
Bock, Cathryn H.
|
|
2017
|
167 |
3 |
p. 741-749
|
artikel
|
| 22 |
The value of embedding: integrated palliative care for patients with metastatic breast cancer
|
Rabow, M.
|
|
2017
|
167 |
3 |
p. 703-708
|
artikel
|
| 23 |
The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel
|
Bernstein-Molho, Rinat
|
|
2017
|
167 |
3 |
p. 697-702
|
artikel
|
| 24 |
Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial
|
Going, Catherine C.
|
|
2017
|
167 |
3 |
p. 797-802
|
artikel
|
| 25 |
Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers
|
Evans, DG
|
|
2017
|
167 |
3 |
p. 779-785
|
artikel
|
Tijdschrift beschrijving